Predictors of injection drug use cessation among Puerto Rican drug injectors in New York and Puerto Rico

American Journal of Drug and Alcohol Abuse

Volumn 33, Issue 2, 2007, Pages 291-299

  Deren, Sherry ^a   Kang, Sung Yeon ^a   Colón, Hector M ^b   Robles, Rafaela R ^b  

^a NATIONAL DEVELOPMENT AND RESEARCH INSTITUTES   (United States)

^b SCHOOL OF MEDICINE   (Puerto Rico)

Author keywords

HIV AIDS; Injection cessation; Injection drug use; Puerto Ricans

Indexed keywords

METHADONE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CONTROLLED STUDY; DATA ANALYSIS; DRUG ABUSE; DRUG BIOAVAILABILITY; DRUG USE; FEMALE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INJECTION; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; METHADONE TREATMENT; MULTIVARIATE ANALYSIS; PREDICTOR VARIABLE; PUERTO RICO; TREATMENT DURATION; UNITED STATES;

ADOLESCENT; ADULT; FEMALE; HIV INFECTIONS; HUMANS; MALE; MULTIVARIATE ANALYSIS; NEW YORK CITY; PROGNOSIS; PUERTO RICO; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 34248548642     PISSN: 00952990     EISSN: 10979891     Source Type: Journal    
DOI: 10.1080/00952990601175037     Document Type: Article

References (21)

1. Centers for Disease Control and Prevention (CDC). Cases of HIV infection and AIDS in the United States, 2002. HIV=AIDS Surveillance Report. Atlanta, GA, 2002.
2. Puerto Rico Department of Health. HIV/AIDS Surveillance Report, April. San Juan, Puerto Rico: Puerto Rico Department of Health, 2003.
3. Colón HM, Robles RR, Deren S, Sahai H, Finlinson HA, Andia JF, Cruz MA, Kang S-Y, Oliver-Velez D. Between-city variation in frequency of injection among Puerto Rican injection drug users: East Harlem, New York, and Bayamón, Puerto Rico. J Acquired Immune Deficiency Syndromes 2002; 27:405-413.
4. Robles RR, Matos TD, Colón HM, Deren S, Reyes JC, Andía JF, Marrero CA, Sahai H. Determinants of health care use among Puerto Rican drug users in Puerto Rico and New York City. Clinical Infectious Diseases 2003; 37:S392-S403.
5. Brown PD, Levine DP. Infections in injection drug users. Infectious Disease Clinics of North America 2002; 16(Special Issue).
6. Hagan H, Thiede H, Weiss NS, Hopkins SG, Duchin JS, Alexander ER. Sharing of drug preparation equipment as a risk factor for hepatitis C. Am J Public Health 2001; 91:42-46.
7. Galai N, Safaeian M, Vlahov D, Bolotin A, Celentano D, the ALIVE Study. Longitudinal patterns of drug injection behavior in the ALIVE Study cohort. 1988-2000: Description and determinants. Amer J Epidemiology 2003; 30:61-83.
8. Sorensen JL, Copeland AL. Drug abuse treatment as an HIV prevention strategy: A review. Drug Alcohol Depend 2000; 59:17-31.
9. Latkin C, Knowlton A, Hoover D, Mandell W. Drug network characteristics as a predictor of cessation of drug use among adult injection drug users: A prospective study. Amer J Drug Alcohol Abuse 1999; 25:463-473.
10. Kang S-Y, Deren S, Colón HM, Andía JF, Robles RR. (2004). Impact of risk network change on cessation of injection drug use among Puerto Rican drug injectors in New York. Paper presented at the American Public Health Association Annual Meeting, Washington, DC, November.
11. Kang S-Y, Deren S, Andia JF, Colón HM, Robles RR. Egocentric HIV risk networks among Puerto Rican crack users in New York and Puerto Rico: Impact on sex risk behaviors over time. AIDS Edu Prev 2005; 17:53-67.
12. Oliver-Velez D, Finlinson HA, Deren S, Robles RR, Colon HM, Andía JF. Mapping the air-bridge locations: The application of ethnographic mapping techniques to dual-site study of HIV risk behavior determinants in East Harlem, New York and Bayamón, Puerto Rico. Human Organization 2002; 61:262-276.
13. Deren S, Oliver-Velez D, Finlinson HA, Robles RR, Andia JF, Colón HM, Kang S-Y, Shedlin M. Integrating qualitative and quantitative methods: Comparing HIV-related risk behaviors among Puerto Rican drug users in Puerto Rico and New York. Substance Use and Misuse 2003; 38:1-24.
14. Kang S-Y, Deren S, Andía JF, Colón HM, Robles RR. Effects of changes in perceived self-efficacy on HIV risk behaviors over time. Addictive Behaviors 2004; 29:567-574.
15. Estébanez P, Zunzunegui MV, Aguilar MD, Russell N, Cifuentes I, Hankins C. The role of prisons in the HIV epidemic among female injecting drug users. AIDS Care 2002; 14:95-104.
16. Andia JF, Deren S, Robles RR, Kang S-Y, Colón HM, Oliver-Velez D, Finlinson HA. Factors associated with injection and non-injection drug use during incarceration among Puerto Rican drug injectors in New York and Puerto Rico. The Prison Journal 2005; 85:329-342.
17. Finlinson HA, Oliver-Vélez D, Colón HM, Deren S, Robles RR, Beardsley M, Cant JGH, Andía JF, Soto-López M. Syringe acquisition and use of syringe exchange programs by Puerto Rican drug injectors in New York and Puerto Rico: Comparisons based on quantitative and qualitative methods. AIDS Behav 2000; 4:341-351.
18. Schechter M, Strathdee S, Cornelisse P, Currie S, Patrick D, Rekart M, O'Shaughnessy M. Do needle exchange programmes increase the spread of HIV among injection drug users?: An investigation of the Vancouver outbreak. AIDS 1999; 13:45-51.
19. Steensma C, Boivin J-F, Blais L, Roy E. Cessation of injecting drug use among street-based youth. J Urban Health 2005; 82:622-637
20. Kang S-Y, Deren S, Andia JF, Colón HM, Robles RR, Oliver-Velez D. HIV transmission behaviors in jail/prison among Puerto Rican drug injectors in New York and Puerto Rico. AIDS Behav 2005; 9:377-338
21. Bruneau J, Brogly S, Tyndall M, Lamothe F, Franco E. Intensity of drug injection as a determinant of sustained injection cessation among chronic drug users: The interface with social factors and service utilization. Addiction 2004; 99:727-737.